Pharmacological treatment of early psychosis: risks and benefits

ABSTRACT: Psychiatry has changed a lot during the last decades and lot of effort has been made to ensure that treatment of schizophrenia spectrum disorders is in line with modern science of medicine. Therefore, in everyday practice the psychiatrist is in a constant process of decision making when to...

Descripción completa

Detalles Bibliográficos
Autor principal: Sīle, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417721/
http://dx.doi.org/10.1192/j.eurpsy.2023.121
_version_ 1785088106179854336
author Sīle, L.
author_facet Sīle, L.
author_sort Sīle, L.
collection PubMed
description ABSTRACT: Psychiatry has changed a lot during the last decades and lot of effort has been made to ensure that treatment of schizophrenia spectrum disorders is in line with modern science of medicine. Therefore, in everyday practice the psychiatrist is in a constant process of decision making when to start pharmacological treatment of early psychosis and with what dosage. The lecture will include evidence-based treatment options, the aspects of clinical practice and the power of shared decision-making in psychiatry. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10417721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104177212023-08-12 Pharmacological treatment of early psychosis: risks and benefits Sīle, L. Eur Psychiatry Abstract ABSTRACT: Psychiatry has changed a lot during the last decades and lot of effort has been made to ensure that treatment of schizophrenia spectrum disorders is in line with modern science of medicine. Therefore, in everyday practice the psychiatrist is in a constant process of decision making when to start pharmacological treatment of early psychosis and with what dosage. The lecture will include evidence-based treatment options, the aspects of clinical practice and the power of shared decision-making in psychiatry. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10417721/ http://dx.doi.org/10.1192/j.eurpsy.2023.121 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Sīle, L.
Pharmacological treatment of early psychosis: risks and benefits
title Pharmacological treatment of early psychosis: risks and benefits
title_full Pharmacological treatment of early psychosis: risks and benefits
title_fullStr Pharmacological treatment of early psychosis: risks and benefits
title_full_unstemmed Pharmacological treatment of early psychosis: risks and benefits
title_short Pharmacological treatment of early psychosis: risks and benefits
title_sort pharmacological treatment of early psychosis: risks and benefits
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417721/
http://dx.doi.org/10.1192/j.eurpsy.2023.121
work_keys_str_mv AT silel pharmacologicaltreatmentofearlypsychosisrisksandbenefits

Ejemplares similares